View Future GrowthEmdeki Utama 過去の業績過去 基準チェック /36Emdeki Utamaの収益は年間平均-4.4%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間12.9% 4.6%割合で 減少しています。 Emdeki Utamaの自己資本利益率は3.2%であり、純利益率は9.7%です。主要情報-4.40%収益成長率-4.66%EPS成長率Chemicals 業界の成長8.96%収益成長率-4.58%株主資本利益率3.20%ネット・マージン9.68%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • May 05First quarter 2026 earnings released: EPS: Rp2.00 (vs Rp3.96 in 1Q 2025)First quarter 2026 results: EPS: Rp2.00 (down from Rp3.96 in 1Q 2025). Revenue: Rp71.6b (down 2.8% from 1Q 2025). Net income: Rp6.30b (down 37% from 1Q 2025). Profit margin: 8.8% (down from 14% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 02Full year 2025 earnings released: EPS: Rp14.00 (vs Rp10.89 in FY 2024)Full year 2025 results: EPS: Rp14.00 (up from Rp10.89 in FY 2024). Revenue: Rp319.2b (down 7.3% from FY 2024). Net income: Rp34.4b (up 25% from FY 2024). Profit margin: 11% (up from 8.0% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.Reported Earnings • Nov 04Third quarter 2025 earnings released: EPS: Rp2.89 (vs Rp3.13 in 3Q 2024)Third quarter 2025 results: EPS: Rp2.89 (down from Rp3.13 in 3Q 2024). Revenue: Rp78.4b (down 17% from 3Q 2024). Net income: Rp6.26b (down 21% from 3Q 2024). Profit margin: 8.0% (down from 8.4% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 02Second quarter 2024 earnings released: EPS: Rp0.99 (vs Rp4.08 in 2Q 2023)Second quarter 2024 results: EPS: Rp0.99 (down from Rp4.08 in 2Q 2023). Revenue: Rp64.5b (down 45% from 2Q 2023). Net income: Rp2.48b (down 76% from 2Q 2023). Profit margin: 3.9% (down from 8.8% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • May 04First quarter 2024 earnings released: EPS: Rp3.00 (vs Rp5.22 in 1Q 2023)First quarter 2024 results: EPS: Rp3.00 (down from Rp5.22 in 1Q 2023). Revenue: Rp85.0b (down 20% from 1Q 2023). Net income: Rp8.85b (down 33% from 1Q 2023). Profit margin: 10% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Apr 04Full year 2023 earnings released: EPS: Rp19.00 (vs Rp15.00 in FY 2022)Full year 2023 results: EPS: Rp19.00 (up from Rp15.00 in FY 2022). Revenue: Rp470.7b (down 3.3% from FY 2022). Net income: Rp47.8b (up 26% from FY 2022). Profit margin: 10% (up from 7.8% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.すべての更新を表示Recent updatesReported Earnings • May 05First quarter 2026 earnings released: EPS: Rp2.00 (vs Rp3.96 in 1Q 2025)First quarter 2026 results: EPS: Rp2.00 (down from Rp3.96 in 1Q 2025). Revenue: Rp71.6b (down 2.8% from 1Q 2025). Net income: Rp6.30b (down 37% from 1Q 2025). Profit margin: 8.8% (down from 14% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.お知らせ • Apr 25PT Emdeki Utama Tbk, Annual General Meeting, Jun 02, 2026PT Emdeki Utama Tbk, Annual General Meeting, Jun 02, 2026.Reported Earnings • Apr 02Full year 2025 earnings released: EPS: Rp14.00 (vs Rp10.89 in FY 2024)Full year 2025 results: EPS: Rp14.00 (up from Rp10.89 in FY 2024). Revenue: Rp319.2b (down 7.3% from FY 2024). Net income: Rp34.4b (up 25% from FY 2024). Profit margin: 11% (up from 8.0% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.Reported Earnings • Nov 04Third quarter 2025 earnings released: EPS: Rp2.89 (vs Rp3.13 in 3Q 2024)Third quarter 2025 results: EPS: Rp2.89 (down from Rp3.13 in 3Q 2024). Revenue: Rp78.4b (down 17% from 3Q 2024). Net income: Rp6.26b (down 21% from 3Q 2024). Profit margin: 8.0% (down from 8.4% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Board Change • Oct 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 28PT Emdeki Utama Tbk announces Annual dividend, payable on June 25, 2025PT Emdeki Utama Tbk announced Annual dividend of IDR 8.0000 per share payable on June 25, 2025, ex-date on June 04, 2025 and record date on June 05, 2025.お知らせ • May 01PT Emdeki Utama Tbk, Annual General Meeting, May 22, 2025PT Emdeki Utama Tbk, Annual General Meeting, May 22, 2025. Location: hotel aston prioritysimatupang, skyballroom priority1, lantai 26, jl let.jend., t.b. simatupang kav 9, kebagusan, jakarta selatan, 12520 kota adm. jakarta selatan dki., jakarta IndonesiaReported Earnings • Aug 02Second quarter 2024 earnings released: EPS: Rp0.99 (vs Rp4.08 in 2Q 2023)Second quarter 2024 results: EPS: Rp0.99 (down from Rp4.08 in 2Q 2023). Revenue: Rp64.5b (down 45% from 2Q 2023). Net income: Rp2.48b (down 76% from 2Q 2023). Profit margin: 3.9% (down from 8.8% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.お知らせ • May 18PT Emdeki Utama Tbk, Annual General Meeting, Jun 24, 2024PT Emdeki Utama Tbk, Annual General Meeting, Jun 24, 2024.Reported Earnings • May 04First quarter 2024 earnings released: EPS: Rp3.00 (vs Rp5.22 in 1Q 2023)First quarter 2024 results: EPS: Rp3.00 (down from Rp5.22 in 1Q 2023). Revenue: Rp85.0b (down 20% from 1Q 2023). Net income: Rp8.85b (down 33% from 1Q 2023). Profit margin: 10% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Apr 04Full year 2023 earnings released: EPS: Rp19.00 (vs Rp15.00 in FY 2022)Full year 2023 results: EPS: Rp19.00 (up from Rp15.00 in FY 2022). Revenue: Rp470.7b (down 3.3% from FY 2022). Net income: Rp47.8b (up 26% from FY 2022). Profit margin: 10% (up from 7.8% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 05Third quarter 2023 earnings released: EPS: Rp4.70 (vs Rp3.65 in 3Q 2022)Third quarter 2023 results: EPS: Rp4.70 (up from Rp3.65 in 3Q 2022). Revenue: Rp121.8b (up 1.5% from 3Q 2022). Net income: Rp12.0b (up 30% from 3Q 2022). Profit margin: 9.8% (up from 7.7% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 8% per year.Reported Earnings • Aug 05Second quarter 2023 earnings released: EPS: Rp4.08 (vs Rp2.30 in 2Q 2022)Second quarter 2023 results: EPS: Rp4.08 (up from Rp2.30 in 2Q 2022). Revenue: Rp117.5b (flat on 2Q 2022). Net income: Rp10.3b (up 78% from 2Q 2022). Profit margin: 8.8% (up from 5.0% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 11% per year.Reported Earnings • Apr 06Full year 2022 earnings released: EPS: Rp15.00 (vs Rp15.30 in FY 2021)Full year 2022 results: EPS: Rp15.00 (down from Rp15.30 in FY 2021). Revenue: Rp486.9b (up 23% from FY 2021). Net income: Rp38.0b (down 2.0% from FY 2021). Profit margin: 7.8% (down from 9.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.Board Change • Nov 16Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 4 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Director Vincent Secapramana is the most experienced director on the board, commencing their role in 2010. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: Rp2.34 (vs Rp2.85 in 2Q 2021)Second quarter 2022 results: EPS: Rp2.34 (down from Rp2.85 in 2Q 2021). Revenue: Rp116.8b (up 17% from 2Q 2021). Net income: Rp5.82b (down 19% from 2Q 2021). Profit margin: 5.0% (down from 7.2% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 02First quarter 2022 earnings released: EPS: Rp2.40 (vs Rp2.21 in 1Q 2021)First quarter 2022 results: EPS: Rp2.40 (up from Rp2.21 in 1Q 2021). Revenue: Rp109.1b (up 25% from 1Q 2021). Net income: Rp5.98b (up 6.9% from 1Q 2021). Profit margin: 5.5% (down from 6.4% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Board Change • Apr 27Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 4 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Director Vincent Secapramana is the most experienced director on the board, commencing their role in 2010. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Reported Earnings • Apr 08Full year 2021 earnings released: EPS: Rp15.00 (vs Rp15.75 in FY 2020)Full year 2021 results: EPS: Rp15.00 (down from Rp15.75 in FY 2020). Revenue: Rp397.3b (up 14% from FY 2020). Net income: Rp38.7b (down 2.8% from FY 2020). Profit margin: 9.7% (down from 11% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Upcoming Dividend • May 31Upcoming dividend of Rp12.00 per shareEligible shareholders must have bought the stock before 07 June 2021. Payment date: 25 June 2021. Trailing yield: 4.2%. Lower than top quartile of Indonesian dividend payers (4.8%). Higher than average of industry peers (0.3%).Reported Earnings • Apr 09Full year 2020 earnings released: EPS Rp16.00 (vs Rp12.83 in FY 2019)The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: Rp350.0b (flat on FY 2019). Net income: Rp39.8b (up 23% from FY 2019). Profit margin: 11% (up from 9.3% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 6% per year.Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improved over the past weekAfter last week's 27% share price gain to Rp280, the stock is trading at a trailing P/E ratio of 22.3x, up from the previous P/E ratio of 17.5x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 40%.Valuation Update With 7 Day Price Move • Dec 30Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to Rp232, the stock is trading at a trailing P/E ratio of 18.4x, down from the previous P/E ratio of 22.6x. This compares to an average P/E of 17x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 33%.Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 33% share price gain to Rp238, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 14.2x. This compares to an average P/E of 15x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 39%.Is New 90 Day High Low • Dec 08New 90-day high: Rp180The company is up 7.0% from its price of Rp168 on 09 September 2020. The Indonesian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 37% over the same period.Valuation Update With 7 Day Price Move • Nov 28Market bids up stock over the past weekAfter last week's 18% share price gain to Rp179, the stock is trading at a trailing P/E ratio of 14.2x, up from the previous P/E ratio of 12.1x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 2.1%.Is New 90 Day High Low • Nov 12New 90-day low: Rp140The company is down 10.0% from its price of Rp156 on 14 August 2020. The Indonesian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Reported Earnings • Nov 03Third quarter 2020 earnings released: EPS Rp6.38The company reported a soft third quarter result with weaker earnings and revenues, although profit margins were improved. Third quarter 2020 results: Revenue: Rp94.8b (down 8.8% from 3Q 2019). Net income: Rp16.3b (down 2.6% from 3Q 2019). Profit margin: 17% (up from 16% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.収支内訳Emdeki Utama の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史IDX:MDKI 収益、費用、利益 ( )IDR Millions日付収益収益G+A経費研究開発費31 Mar 26317,12330,68940,829031 Dec 25319,17434,41239,112030 Sep 25330,78832,36342,692030 Jun 25346,37534,03238,010031 Mar 25333,07228,71440,128031 Dec 24344,46027,54842,572030 Sep 24368,00731,54347,555030 Jun 24395,84035,60450,126031 Mar 24448,87843,45049,919031 Dec 23470,70047,79550,422030 Sep 23487,10952,42448,606030 Jun 23485,32649,68350,911031 Mar 23484,64145,17251,954031 Dec 22486,87637,95053,743030 Sep 22452,16536,48150,810030 Jun 22436,15637,70050,547031 Mar 22418,98139,09552,151031 Dec 21397,30838,71050,215030 Sep 21390,91932,92351,188030 Jun 21381,72838,72746,777031 Mar 21365,01140,65543,907031 Dec 20349,98339,83941,786030 Sep 20348,01131,84047,649030 Jun 20357,21432,27847,990031 Mar 20355,22029,81746,366031 Dec 19349,57932,45745,555030 Sep 19353,34835,19540,615030 Jun 19353,42430,93040,474031 Mar 19364,10136,30941,339031 Dec 18399,19333,50842,896030 Sep 18394,27923,31639,729030 Jun 18388,83927,49237,756031 Mar 18392,58836,82035,657031 Dec 17368,17446,85334,016030 Sep 17364,42191,16630,422031 Mar 17338,74962,35525,642031 Dec 16339,98586,69123,382031 Dec 15304,3905,62917,5360質の高い収益: MDKIは 高品質の収益 を持っています。利益率の向上: MDKIの現在の純利益率 (9.7%)は、昨年(8.6%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: MDKIの収益は過去 5 年間で年間4.4%減少しました。成長の加速: MDKIの過去 1 年間の収益成長率 ( 6.9% ) は、5 年間の平均 ( 年間-4.4%を上回っています。収益対業界: MDKIの過去 1 年間の収益成長率 ( 6.9% ) Chemicals業界12%を上回りませんでした。株主資本利益率高いROE: MDKIの 自己資本利益率 ( 3.2% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 11:07終値2026/05/26 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋PT Emdeki Utama Tbk 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 05First quarter 2026 earnings released: EPS: Rp2.00 (vs Rp3.96 in 1Q 2025)First quarter 2026 results: EPS: Rp2.00 (down from Rp3.96 in 1Q 2025). Revenue: Rp71.6b (down 2.8% from 1Q 2025). Net income: Rp6.30b (down 37% from 1Q 2025). Profit margin: 8.8% (down from 14% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 02Full year 2025 earnings released: EPS: Rp14.00 (vs Rp10.89 in FY 2024)Full year 2025 results: EPS: Rp14.00 (up from Rp10.89 in FY 2024). Revenue: Rp319.2b (down 7.3% from FY 2024). Net income: Rp34.4b (up 25% from FY 2024). Profit margin: 11% (up from 8.0% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 04Third quarter 2025 earnings released: EPS: Rp2.89 (vs Rp3.13 in 3Q 2024)Third quarter 2025 results: EPS: Rp2.89 (down from Rp3.13 in 3Q 2024). Revenue: Rp78.4b (down 17% from 3Q 2024). Net income: Rp6.26b (down 21% from 3Q 2024). Profit margin: 8.0% (down from 8.4% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 02Second quarter 2024 earnings released: EPS: Rp0.99 (vs Rp4.08 in 2Q 2023)Second quarter 2024 results: EPS: Rp0.99 (down from Rp4.08 in 2Q 2023). Revenue: Rp64.5b (down 45% from 2Q 2023). Net income: Rp2.48b (down 76% from 2Q 2023). Profit margin: 3.9% (down from 8.8% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • May 04First quarter 2024 earnings released: EPS: Rp3.00 (vs Rp5.22 in 1Q 2023)First quarter 2024 results: EPS: Rp3.00 (down from Rp5.22 in 1Q 2023). Revenue: Rp85.0b (down 20% from 1Q 2023). Net income: Rp8.85b (down 33% from 1Q 2023). Profit margin: 10% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Apr 04Full year 2023 earnings released: EPS: Rp19.00 (vs Rp15.00 in FY 2022)Full year 2023 results: EPS: Rp19.00 (up from Rp15.00 in FY 2022). Revenue: Rp470.7b (down 3.3% from FY 2022). Net income: Rp47.8b (up 26% from FY 2022). Profit margin: 10% (up from 7.8% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • May 05First quarter 2026 earnings released: EPS: Rp2.00 (vs Rp3.96 in 1Q 2025)First quarter 2026 results: EPS: Rp2.00 (down from Rp3.96 in 1Q 2025). Revenue: Rp71.6b (down 2.8% from 1Q 2025). Net income: Rp6.30b (down 37% from 1Q 2025). Profit margin: 8.8% (down from 14% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 25PT Emdeki Utama Tbk, Annual General Meeting, Jun 02, 2026PT Emdeki Utama Tbk, Annual General Meeting, Jun 02, 2026.
Reported Earnings • Apr 02Full year 2025 earnings released: EPS: Rp14.00 (vs Rp10.89 in FY 2024)Full year 2025 results: EPS: Rp14.00 (up from Rp10.89 in FY 2024). Revenue: Rp319.2b (down 7.3% from FY 2024). Net income: Rp34.4b (up 25% from FY 2024). Profit margin: 11% (up from 8.0% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 04Third quarter 2025 earnings released: EPS: Rp2.89 (vs Rp3.13 in 3Q 2024)Third quarter 2025 results: EPS: Rp2.89 (down from Rp3.13 in 3Q 2024). Revenue: Rp78.4b (down 17% from 3Q 2024). Net income: Rp6.26b (down 21% from 3Q 2024). Profit margin: 8.0% (down from 8.4% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Board Change • Oct 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 28PT Emdeki Utama Tbk announces Annual dividend, payable on June 25, 2025PT Emdeki Utama Tbk announced Annual dividend of IDR 8.0000 per share payable on June 25, 2025, ex-date on June 04, 2025 and record date on June 05, 2025.
お知らせ • May 01PT Emdeki Utama Tbk, Annual General Meeting, May 22, 2025PT Emdeki Utama Tbk, Annual General Meeting, May 22, 2025. Location: hotel aston prioritysimatupang, skyballroom priority1, lantai 26, jl let.jend., t.b. simatupang kav 9, kebagusan, jakarta selatan, 12520 kota adm. jakarta selatan dki., jakarta Indonesia
Reported Earnings • Aug 02Second quarter 2024 earnings released: EPS: Rp0.99 (vs Rp4.08 in 2Q 2023)Second quarter 2024 results: EPS: Rp0.99 (down from Rp4.08 in 2Q 2023). Revenue: Rp64.5b (down 45% from 2Q 2023). Net income: Rp2.48b (down 76% from 2Q 2023). Profit margin: 3.9% (down from 8.8% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
お知らせ • May 18PT Emdeki Utama Tbk, Annual General Meeting, Jun 24, 2024PT Emdeki Utama Tbk, Annual General Meeting, Jun 24, 2024.
Reported Earnings • May 04First quarter 2024 earnings released: EPS: Rp3.00 (vs Rp5.22 in 1Q 2023)First quarter 2024 results: EPS: Rp3.00 (down from Rp5.22 in 1Q 2023). Revenue: Rp85.0b (down 20% from 1Q 2023). Net income: Rp8.85b (down 33% from 1Q 2023). Profit margin: 10% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Apr 04Full year 2023 earnings released: EPS: Rp19.00 (vs Rp15.00 in FY 2022)Full year 2023 results: EPS: Rp19.00 (up from Rp15.00 in FY 2022). Revenue: Rp470.7b (down 3.3% from FY 2022). Net income: Rp47.8b (up 26% from FY 2022). Profit margin: 10% (up from 7.8% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 05Third quarter 2023 earnings released: EPS: Rp4.70 (vs Rp3.65 in 3Q 2022)Third quarter 2023 results: EPS: Rp4.70 (up from Rp3.65 in 3Q 2022). Revenue: Rp121.8b (up 1.5% from 3Q 2022). Net income: Rp12.0b (up 30% from 3Q 2022). Profit margin: 9.8% (up from 7.7% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 8% per year.
Reported Earnings • Aug 05Second quarter 2023 earnings released: EPS: Rp4.08 (vs Rp2.30 in 2Q 2022)Second quarter 2023 results: EPS: Rp4.08 (up from Rp2.30 in 2Q 2022). Revenue: Rp117.5b (flat on 2Q 2022). Net income: Rp10.3b (up 78% from 2Q 2022). Profit margin: 8.8% (up from 5.0% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 11% per year.
Reported Earnings • Apr 06Full year 2022 earnings released: EPS: Rp15.00 (vs Rp15.30 in FY 2021)Full year 2022 results: EPS: Rp15.00 (down from Rp15.30 in FY 2021). Revenue: Rp486.9b (up 23% from FY 2021). Net income: Rp38.0b (down 2.0% from FY 2021). Profit margin: 7.8% (down from 9.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.
Board Change • Nov 16Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 4 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Director Vincent Secapramana is the most experienced director on the board, commencing their role in 2010. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: Rp2.34 (vs Rp2.85 in 2Q 2021)Second quarter 2022 results: EPS: Rp2.34 (down from Rp2.85 in 2Q 2021). Revenue: Rp116.8b (up 17% from 2Q 2021). Net income: Rp5.82b (down 19% from 2Q 2021). Profit margin: 5.0% (down from 7.2% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 02First quarter 2022 earnings released: EPS: Rp2.40 (vs Rp2.21 in 1Q 2021)First quarter 2022 results: EPS: Rp2.40 (up from Rp2.21 in 1Q 2021). Revenue: Rp109.1b (up 25% from 1Q 2021). Net income: Rp5.98b (up 6.9% from 1Q 2021). Profit margin: 5.5% (down from 6.4% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Board Change • Apr 27Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 4 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Director Vincent Secapramana is the most experienced director on the board, commencing their role in 2010. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Reported Earnings • Apr 08Full year 2021 earnings released: EPS: Rp15.00 (vs Rp15.75 in FY 2020)Full year 2021 results: EPS: Rp15.00 (down from Rp15.75 in FY 2020). Revenue: Rp397.3b (up 14% from FY 2020). Net income: Rp38.7b (down 2.8% from FY 2020). Profit margin: 9.7% (down from 11% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Upcoming Dividend • May 31Upcoming dividend of Rp12.00 per shareEligible shareholders must have bought the stock before 07 June 2021. Payment date: 25 June 2021. Trailing yield: 4.2%. Lower than top quartile of Indonesian dividend payers (4.8%). Higher than average of industry peers (0.3%).
Reported Earnings • Apr 09Full year 2020 earnings released: EPS Rp16.00 (vs Rp12.83 in FY 2019)The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: Rp350.0b (flat on FY 2019). Net income: Rp39.8b (up 23% from FY 2019). Profit margin: 11% (up from 9.3% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 6% per year.
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improved over the past weekAfter last week's 27% share price gain to Rp280, the stock is trading at a trailing P/E ratio of 22.3x, up from the previous P/E ratio of 17.5x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 40%.
Valuation Update With 7 Day Price Move • Dec 30Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to Rp232, the stock is trading at a trailing P/E ratio of 18.4x, down from the previous P/E ratio of 22.6x. This compares to an average P/E of 17x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 33%.
Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 33% share price gain to Rp238, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 14.2x. This compares to an average P/E of 15x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 39%.
Is New 90 Day High Low • Dec 08New 90-day high: Rp180The company is up 7.0% from its price of Rp168 on 09 September 2020. The Indonesian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 37% over the same period.
Valuation Update With 7 Day Price Move • Nov 28Market bids up stock over the past weekAfter last week's 18% share price gain to Rp179, the stock is trading at a trailing P/E ratio of 14.2x, up from the previous P/E ratio of 12.1x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 2.1%.
Is New 90 Day High Low • Nov 12New 90-day low: Rp140The company is down 10.0% from its price of Rp156 on 14 August 2020. The Indonesian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Reported Earnings • Nov 03Third quarter 2020 earnings released: EPS Rp6.38The company reported a soft third quarter result with weaker earnings and revenues, although profit margins were improved. Third quarter 2020 results: Revenue: Rp94.8b (down 8.8% from 3Q 2019). Net income: Rp16.3b (down 2.6% from 3Q 2019). Profit margin: 17% (up from 16% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.